IL17A and breast cancer: Treatment of doxorubicin promoted cytotoxic T lymphocytes accumulation by a potent production of IFN-γ and IL-17 in a BC mouse model, which suggested that γδ T cells indeed played a sizable role in doxorubicin-induced anti-tumor immune response (97).